The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
Abstract
Interleukin-12 (IL-12) is a cytokine that promotes cell-mediated immunity to intracellular pathogens by inducing type 1 helper T cell (T H 1) responses and interferon-γ (IFN-γ) production. IL-12 binds to high-affinity β1/β2 heterodimeric IL-12 receptor (IL-12R) complexes on T cell and natural killer cells. Three unrelated individuals with severe, idiopathic mycobacterial and S almonella infections were found to lack IL-12Rβ1 chain expression. Their cells were deficient in IL-12R signaling and IFN-γ production, and their remaining T cell responses were independent of endogenous IL-12. IL-12Rβ1 sequence analysis revealed genetic mutations that resulted in premature stop codons in the extracellular domain. The lack of IL-12Rβ1 expression results in a human immunodeficiency and shows the essential role of IL-12 in resistance to infections due to intracellular bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.-F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 895
Self-citationImpairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Self-citationSelective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C.-Y., Gately, M. K., & Gubler, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14002 · Cited by 689
Jouanguy, E., Lamhamedi-Cherradi, S., Altare, F., Fondanèche, M. C., Tuerlinckx, D., Blanche, S., Emile, J. F., Gaillard, J. L., Schreiber, R., Levin, M., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119810 · Cited by 377
Self-citationA suggested nomenclature for designating mutations
Beaudet, A. L., & Tsui, L.-C. (1993) · Human Mutation · doi:10.1002/humu.1380020402 · Cited by 308
Holland, S. M., Eisenstein, E. M., Kuhns, D. B., Turner, M. L., Fleisher, T. A., Strober, W., & Gallin, J. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301904 · Cited by 302
Cited by
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
CD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,798
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
Fang, F. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1004 · Cited by 1,676
“In humans, mutations in the IL-12 receptor or other elements of the IL-12–IFN-γ signalling pair have been associated with increased susceptibility to mycobacterial and Salmonella infection”
BackgroundRegulation of Interferon‐γ During Innate and Adaptive Immune Responses
(2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96002-2 · Cited by 1,655
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Self-citationT-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Self-citationNew IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
Hunter, C. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1648 · Cited by 852
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Self-citationA Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 702
Salmonella, the host and disease: a brief review
Coburn, B., Grassl, G. A., & Finlay, B. B. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100007 · Cited by 690
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Self-citationSignaling and Transcription in T Helper Development
Murphy, K. M., Ouyang, W., Farrar, J. D., Yang, J., Ranganath, S., Asnagli, H., Afkarian, M., & Murphy, T. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.451 · Cited by 633
Innate Immunity to Mycobacterium tuberculosis
van Crevel, R., Ottenhoff, T. H. M., & van der Meer, J. W. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.294-309.2002 · Cited by 598
Self-citationManca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
The biology of IL-12: coordinating innate and adaptive immune responses
Watford, W. T., Moriguchi, M., Morinobu, A., & O’Shea, J. J. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00043-1 · Cited by 576
Human macrophage activation programs induced by bacterial pathogens
Nau, G. J., Richmond, J. F. L., Schlesinger, A., Jennings, E. G., Lander, E. S., & Young, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022649799 · Cited by 568
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Bernstein, I. L., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Kobrynski, L. J., Levinson, A. I., Mazer, B., Nelson, R. P., et al. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61142-8 · Cited by 521
Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation
Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., & Casanova, J.-L. (2001) · Science · doi:10.1126/science.1061154 · Cited by 517
Self-citationHaskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondanèche, M.-C., Dupuis, S., Döffinger, R., Altare, F., Girdlestone, J., Emile, J.-F., et al. (1999) · Nature Genetics · doi:10.1038/7701 · Cited by 492
Self-citationThe IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection
Villarino, A., Hibbert, L., Lieberman, L., Wilson, E., Mak, T., Yoshida, H., Kastelein, R. A., Saris, C., & Hunter, C. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00300-5 · Cited by 484
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
Capuano, S. V., Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E., & Flynn, J. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5831-5844.2003 · Cited by 479
Therapy of tuberculosis in mice by DNA vaccination
Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., & Silva, C. L. (1999) · Nature · doi:10.1038/22326 · Cited by 474
Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features
Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg, J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., et al. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.010 · Cited by 464
Self-citationGenetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., & Coccia, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7033 · Cited by 433
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease
Ogus, A. C., Yoldas, B., Ozdemir, T., Uguz, A., Olcen, S., Keser, I., Coskun, M., Cilli, A., & Yegin, O. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00061703 · Cited by 423
Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., & Puzo, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7477 · Cited by 423
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
Innate Immune Recognition of Mycobacterium tuberculosis
Kleinnijenhuis, J., Oosting, M., Joosten, L. A. B., Netea, M. G., & Van Crevel, R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/405310 · Cited by 414
Altare, F., Lammas, D., Revy, P., Jouanguy, E., Döffinger, R., Lamhamedi, S., Drysdale, P., Scheel-Toellner, D., Girdlestone, J., Darbyshire, P., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4950 · Cited by 413
Self-citationIL-10–producing T cells suppress immune responses in anergic tuberculosis patients
Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., Berezovskaya, A., Rousset, D., Reynes, J.-M., & Goldfeld, A. E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9918 · Cited by 398
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannière, L., Rose, Y., de Suremain, M., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fdd832 · Cited by 394
Self-citationCytokines and immunodeficiency diseases
Leonard, W. J. (2001) · Nature Reviews Immunology · doi:10.1038/35105066 · Cited by 390
Immunodeficiency Diseases Caused by Defects in Phagocytes
Lekstrom-Himes, J. A., & Gallin, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432307 · Cited by 390
Agnello, D., Lankford, C. S. R., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., & Frucht, D. M. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1023381027062 · Cited by 378
Abel, B., Thieblemont, N., Quesniaux, V. J. F., Brown, N., Mpagi, J., Miyake, K., Bihl, F., & Ryffel, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3155 · Cited by 363
Kovanen, P. E., & Leonard, W. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00203.x · Cited by 360
CD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Malley, R., Trzcinski, K., Srivastava, A., Thompson, C. M., Anderson, P. W., & Lipsitch, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501254102 · Cited by 346
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Interferon-γ and interleukin-12 pathway defects and human disease
Dorman, S. E., & Holland, S. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00010-1 · Cited by 336
“It appears that IFNg or IFNGR1 knockout mice are more susceptible than IL-12 p40 or IL-12Rb1 knockout mice to experimental infection with BCG and M. tuberculosis, but no study has directly compared the mycobacterial susceptibilities of these knockout models.”
BackgroundInfluentialOttenhoff, T. H. M., Kumararatne, D., & Casanova, J.-L. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01321-8 · Cited by 324
Self-citationZhang, S., Boisson‐Dupuis, S., Chapgier, A., Yang, K., Bustamante, J., Puel, A., Picard, C., Abel, L., Jouanguy, E., & Casanova, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00698.x · Cited by 321
Self-citationFunctional STAT3 deficiency compromises the generation of human T follicular helper cells
Ma, C. S., Avery, D. T., Chan, A., Batten, M., Bustamante, J., Boisson-Dupuis, S., Arkwright, P. D., Kreins, A. Y., Averbuch, D., Engelhard, D., et al. (2012) · Blood · doi:10.1182/blood-2011-11-392985 · Cited by 314
Self-citationImmunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021769 · Cited by 312
Self-citationManca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Wilkinson, R. J., Patel, P., Llewelyn, M., Hirsch, C. S., Pasvol, G., Snounou, G., Davidson, R. N., & Toossi, Z. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1863 · Cited by 295
Malhotra, I., Mungai, P., Wamachi, A., Kioko, J., Ouma, J. H., Kazura, J. W., & King, C. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6843 · Cited by 286
Type I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K., Sher, A., & O’Garra, A. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 282
Picard, C., Fieschi, C., Altare, F., Al-Jumaah, S., Al-Hajjar, S., Feinberg, J., Dupuis, S., Soudais, C., Al-Mohsen, I. Z., Génin, E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338625 · Cited by 282
Self-citationFilipe-Santos, O., Bustamante, J., Haverkamp, M. H., Vinolo, E., Ku, C.-L., Puel, A., Frucht, D. M., Christel, K., von Bernuth, H., Jouanguy, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060085 · Cited by 282
Self-citationBacteria and cancer: cause, coincidence or cure? A review
Mager, D. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-14 · Cited by 278
Gordon, M. A., Banda, H. T., Gondwe, M., Gordon, S. B., Boeree, M. J., Walsh, A. L., Corkill, J. E., Hart, C. A., Gilks, C. F., & Molyneux, M. E. (2002) · AIDS · doi:10.1097/00002030-200208160-00009 · Cited by 277
Cytokines in host defense against
Eckmann, L., & Kagnoff, M. F. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01479-4 · Cited by 269
The Genomics and Genetics of Human Infectious Disease Susceptibility
Hill, A. V. S. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.373 · Cited by 264
Lienhardt, C. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000807 · Cited by 261
The translation of non-canonical open reading frames controls mucosal immunity
Jackson, R., Kroehling, L., Khitun, A., Bailis, W., Jarret, A., York, A. G., Khan, O. M., Brewer, J. R., Skadow, M. H., Duizer, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0794-7 · Cited by 242
McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J., & Moots, R. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215356 · Cited by 254
Bafica, A., Scanga, C. A., Serhan, C., Machado, F., White, S., Sher, A., & Aliberti, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23949 · Cited by 253
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
Krishnan, N., Robertson, B. D., & Thwaites, G. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.005 · Cited by 178
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
Interleukin-18 (IL-18) Enhances Innate IL-12-Mediated Resistance to Toxoplasma gondii
Cai, G., Kastelein, R., & Hunter, C. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6932-6938.2000 · Cited by 116
CD4 + T Cells: Guardians of the Phagosome
Tubo, N. J., & Jenkins, M. K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-13 · Cited by 105
Interfering with immunity: detrimental role of type I IFNs during infection
Stifter, S. A., & Feng, C. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402794 · Cited by 78
NRAMP1 Gene Polymorphism and Susceptibility to Nontuberculous Mycobacterial Lung Diseases
Koh, W.-J., Kwon, O. J., Kim, E. J., Lee, K. S., Ki, C.-S., & Kim, J. W. (2005) · Chest · doi:10.1378/chest.128.1.94 · Cited by 71
Wu, C.-Y., Maeda, H., Contursi, C., Ozato, K., & Seder, R. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.807 · Cited by 31
Metadata
- Authors
- Jong, R. D., Altare, F., Haagen, I.-A., Elferink, D. G., Boer, T. D., van Breda Vriesman, P. J. C., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., Casanova, J.-L., & Ottenhoff, T. H. M.
- Venue
- Science
- Published
- 1998-05-29
- Volume
- 280
- Issue
- 5368
- Pages
- 1435-1438
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2154218327
- Cited by
- 821
- References
- 23
- FWCI
- 24.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.